2 clinical trials found.
-
A Phase 3 Matrix Design Partially Double-Blind Randomized Study of the Efficacy and Safety of 50 mg Lonafarnib/100 mg Ritonavir BID with and without 180 mcg PEG IFN-alfa-2a for 48 Weeks Compared with PEG IFN-alfa-2a Monotherapy and Placebo Treatment in Patients Chronically Infected with Hepatitis Delta Virus Being Maintained on Anti-HBV Nucleos(t)ide Therapy (D-LIVR)
Although there is no preventative vaccine or approved treatment for HDV, researchers are studying new treatments for HDV. This research study is designed to learn ...
Phase
Interventional
TRIAL ROLE: Principal Investigator
-
An Observational Study of Patients Undergoing Therapy for Chronic Hepatitis B (HBV) Infection
The TARGET-HBV study engages an observational research design to conduct a comprehensive review of therapeutic outcomes for patients with chronic hepatitis B (HBV) who are ...
Phase N/A TRIAL ROLE: Principal Investigator
